The First Affiliated Hospital of Xiamen University
🇨🇳China
Clinical Trials
103
Active:3
Completed:19
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:12
Phase 2:32
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (82 trials with phase data)• Click on a phase to view related trials
Not Applicable
32 (39.0%)Phase 2
32 (39.0%)Phase 1
12 (14.6%)Phase 4
3 (3.7%)Phase 3
2 (2.4%)Early Phase 1
1 (1.2%)68Ga-XACP3 PET/CT in Prostate Cancer
Not Applicable
Recruiting
- Conditions
- Prostate CancerPET/CTACP3
- First Posted Date
- 2025-11-21
- Last Posted Date
- 2025-11-21
- Target Recruit Count
- 60
- Registration Number
- NCT07242014
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy
Not Applicable
Not yet recruiting
- Conditions
- Locally Advanced Breast Cancer (LABC)
- Interventions
- Drug: Pyrotinib Maleate Tablets + Dalpiciclib Isethionate Tablets + Standard Endocrine
- First Posted Date
- 2025-09-24
- Last Posted Date
- 2025-09-24
- Target Recruit Count
- 33
- Registration Number
- NCT07189884
The Effect of Semaglutide on Bone Health
Not Applicable
Not yet recruiting
- Conditions
- OsteoporosisOsteoporosis FractureT2DM
- Interventions
- Drug: semaglutide combined with metformin
- First Posted Date
- 2025-09-10
- Last Posted Date
- 2025-09-17
- Target Recruit Count
- 150
- Registration Number
- NCT07165158
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
PET/CT for Trop2 ADC Response Evaluation NSCLC
Recruiting
- Conditions
- NSCLCTrop2PET/CT
- First Posted Date
- 2025-09-03
- Last Posted Date
- 2025-09-03
- Target Recruit Count
- 50
- Registration Number
- NCT07151898
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients
Completed
- Conditions
- Nasopharyngeal Cancer
- First Posted Date
- 2025-08-24
- Last Posted Date
- 2025-08-24
- Target Recruit Count
- 31
- Registration Number
- NCT07139054
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 21
- Next
News
No news found